Mohammad Ali Khan

Mohammad Ali Khan is currently a Ph.D. Scholar at Jamia Hamdard, working in collaboration with Prof. Md. Imtaiyaz Hassan at the Centre for Interdisciplinary Research in Basic Sciences (CIRBSc), Jamia Millia Islamia, New Delhi, India. His research is primarily focused on discovering and optimizing novel therapeutics to combat cancer. His areas of interest include computational and experimental approaches, including structure-based drug design, molecular modeling, and preclinical evaluations, to develop targeted and effective therapies.

As part of his ongoing research, he is working on a project titled “Discovering Potential Therapeutics for Liver Cancer via Modulating Fyn Kinase”. This project aims to integrate bioinformatics, AI-driven drug discovery, and translational research to bridge the gap between computational predictions and clinical applications. He has contributed to scientific literature with several publications.

1. A Ashraf1, A Choudhary1, M A Khan2, S Noor1, A Hussain3, M F. Alajmi3, and M I Hassan1,* Targeting transcriptional regulatory protein RfaH with natural compounds to develop novel therapies against Klebsiella pneumoniae. Journal of Biomolecular Structure & Dynamics DOI: 10.1080/07391102.2024.2427376

2. A Ashraf1, A Choudhary1, M A Khan2, S Noor1, A Islam1, and M I Hassan1,* Repurposing Rifaximin against Klebsiella pneumoniae via Targeting of Transcription Anti-termination Protein RfaH for Novel Antimicrobial Development. DOI: https://doi.org/10.21203/rs.3.rs-4724428/v1

3. Ashraf, A., Ahmad, M., Mariadasse, R., Khan, M. A., Noor, S., Islam, A., & Hassan, Md. I. (2023). Integrated spectroscopic and MD simulation approach to decipher the effect of pH on the structure-function of Staphylococcus aureus thymidine kinase. Journal of Biomolecular Structure and Dynamics, 1–12. DOI: 10.1080/07391102.2023.2293270